{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T09:20:49Z","timestamp":1791537649994,"version":"4.3.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"7593","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1038\/nature16969","type":"journal-article","created":{"date-parts":[[2016,3,2]],"date-time":"2016-03-02T06:08:48Z","timestamp":1456898928000},"page":"253-257","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":702,"title":["NAFLD causes selective CD4+ T lymphocyte loss and promotes hepatocarcinogenesis"],"prefix":"10.1038","volume":"531","author":[{"given":"Chi","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aparna H.","family":"Kesarwala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Eggert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Medina-Echeverz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Kleiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David F.","family":"Stroncek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Terabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veena","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"ElGindi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaojun","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela M.","family":"Thornton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mich\u00e8le","family":"Egger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean W.","family":"Felsher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel W.","family":"McVicar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achim","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Heikenwalder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim F.","family":"Greten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,2]]},"reference":[{"key":"BFnature16969_CR1","doi-asserted-by":"crossref","unstructured":"European Association For The Study Of The Liver & European Organisation For Research And Treatment Of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J. Hepatol. 56, 908\u2013943 (2012)","DOI":"10.1016\/j.jhep.2011.12.001"},{"key":"BFnature16969_CR2","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.jhep.2011.09.020","volume":"56","author":"B Sun","year":"2012","unstructured":"Sun, B. & Karin, M. Obesity, inflammation, and liver cancer. J. Hepatol. 56, 704\u2013713 (2012)","journal-title":"J. Hepatol."},{"key":"BFnature16969_CR3","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nrgastro.2013.183","volume":"10","author":"GA Michelotti","year":"2013","unstructured":"Michelotti, G. A., Machado, M. V. & Diehl, A. M. NAFLD, NASH and liver cancer. Nature Rev. Gastroenterol. Hepatol. 10, 656\u2013665 (2013)","journal-title":"Nature Rev. Gastroenterol. Hepatol."},{"key":"BFnature16969_CR4","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/jgh.12212","volume":"28","author":"D Schuppan","year":"2013","unstructured":"Schuppan, D. & Schattenberg, J. M. Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches. J. Gastroenterol. Hepatol. 28 (suppl. 1), 68\u201376 (2013)","journal-title":"J. Gastroenterol. Hepatol."},{"key":"BFnature16969_CR5","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/nrgastro.2013.149","volume":"10","author":"A Wree","year":"2013","unstructured":"Wree, A., Broderick, L., Canbay, A., Hoffman, H. M. & Feldstein, A. E. From NAFLD to NASH to cirrhosis\u2014new insights into disease mechanisms. Nature Rev. Gastroenterol. Hepatol. 10, 627\u2013636 (2013)","journal-title":"Nature Rev. Gastroenterol. Hepatol."},{"key":"BFnature16969_CR6","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1136\/gutjnl-2014-307990","volume":"64","author":"TF Greten","year":"2015","unstructured":"Greten, T. F., Wang, X. W. & Korangy, F. Current concepts of immune based treatments for patients with HCC: from basic science to novel treatment approaches. Gut 64, 842\u2013848 (2015)","journal-title":"Gut"},{"key":"BFnature16969_CR7","doi-asserted-by":"publisher","first-page":"6678","DOI":"10.1158\/1078-0432.CCR-13-1721","volume":"19","author":"TF Greten","year":"2013","unstructured":"Greten, T. F., Duffy, A. G. & Korangy, F. Hepatocellular carcinoma from an immunologic perspective. Clin. Cancer Res. 19, 6678\u20136685 (2013)","journal-title":"Clin. Cancer Res."},{"key":"BFnature16969_CR8","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.ccell.2014.09.003","volume":"26","author":"MJ Wolf","year":"2014","unstructured":"Wolf, M. J. et al. Metabolic activation of intrahepatic CD8+ T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes. Cancer Cell 26, 549\u2013564 (2014)","journal-title":"Cancer Cell"},{"key":"BFnature16969_CR9","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1038\/nature03043","volume":"431","author":"CM Shachaf","year":"2004","unstructured":"Shachaf, C. M. et al. MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer. Nature 431, 1112\u20131117 (2004)","journal-title":"Nature"},{"key":"BFnature16969_CR10","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1194\/jlr.M800042-JLR200","volume":"49","author":"ME Rinella","year":"2008","unstructured":"Rinella, M. E. et al. Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet. J. Lipid Res. 49, 1068\u20131076 (2008)","journal-title":"J. Lipid Res."},{"key":"BFnature16969_CR11","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/hep.26698","volume":"59","author":"L Yang","year":"2014","unstructured":"Yang, L. et al. Transforming growth factor \u03b2 signaling in hepatocytes participates in steatohepatitis through regulation of cell death and lipid metabolism in mice. Hepatology 59, 483\u2013495 (2014)","journal-title":"Hepatology"},{"key":"BFnature16969_CR12","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.cell.2009.12.052","volume":"140","author":"EJ Park","year":"2010","unstructured":"Park, E. J. et al. Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell 140, 197\u2013208 (2010)","journal-title":"Cell"},{"key":"BFnature16969_CR13","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.jhep.2013.06.010","volume":"59","author":"T Kapanadze","year":"2013","unstructured":"Kapanadze, T. et al. Regulation of accumulation and function of myeloid derived suppressor cells in different murine models of hepatocellular carcinoma. J. Hepatol. 59, 1007\u20131013 (2013)","journal-title":"J. Hepatol."},{"key":"BFnature16969_CR14","doi-asserted-by":"publisher","first-page":"23591","DOI":"10.1074\/jbc.M111.237123","volume":"286","author":"S Xia","year":"2011","unstructured":"Xia, S. et al. Gr-1+ CD11b+ myeloid-derived suppressor cells suppress inflammation and promote insulin sensitivity in obesity. J. Biol. Chem. 286, 23591\u201323599 (2011)","journal-title":"J. Biol. Chem."},{"key":"BFnature16969_CR15","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1136\/gutjnl-2011-300304","volume":"61","author":"C Baeck","year":"2012","unstructured":"Baeck, C. et al. Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury. Gut 61, 416\u2013426 (2012)","journal-title":"Gut"},{"key":"BFnature16969_CR16","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/hep.26267","volume":"58","author":"JR Henning","year":"2013","unstructured":"Henning, J. R. et al. Dendritic cells limit fibroinflammatory injury in nonalcoholic steatohepatitis in mice. Hepatology 58, 589\u2013602 (2013)","journal-title":"Hepatology"},{"key":"BFnature16969_CR17","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1002\/hep.21823","volume":"46","author":"X Ma","year":"2007","unstructured":"Ma, X. et al. A high-fat diet and regulatory T cells influence susceptibility to endotoxin-induced liver injury. Hepatology 46, 1519\u20131529 (2007)","journal-title":"Hepatology"},{"key":"BFnature16969_CR18","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.ccr.2010.10.002","volume":"18","author":"K Rakhra","year":"2010","unstructured":"Rakhra, K. et al. CD4+ T cells contribute to the remodeling of the microenvironment required for sustained tumor regression upon oncogene inactivation. Cancer Cell 18, 485\u2013498 (2010)","journal-title":"Cancer Cell"},{"key":"BFnature16969_CR19","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nature10599","volume":"479","author":"TW Kang","year":"2011","unstructured":"Kang, T. W. et al. Senescence surveillance of pre-malignant hepatocytes limits liver cancer development. Nature 479, 547\u2013551 (2011)","journal-title":"Nature"},{"key":"BFnature16969_CR20","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/nature14426","volume":"520","author":"S Kreiter","year":"2015","unstructured":"Kreiter, S. et al. Mutant MHC class II epitopes drive therapeutic immune responses to cancer. Nature 520, 692\u2013696 (2015)","journal-title":"Nature"},{"key":"BFnature16969_CR21","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1007\/s00125-015-3656-y","volume":"58","author":"P Giesbertz","year":"2015","unstructured":"Giesbertz, P. et al. Metabolite profiling in plasma and tissues of ob\/ob and db\/db mice identifies novel markers of obesity and type 2 diabetes. Diabetologia 58, 2133\u20132143 (2015)","journal-title":"Diabetologia"},{"key":"BFnature16969_CR22","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.freeradbiomed.2008.04.029","volume":"45","author":"P Sch\u00f6nfeld","year":"2008","unstructured":"Sch\u00f6nfeld, P. & Wojtczak, L. Fatty acids as modulators of the cellular production of reactive oxygen species. Free Radic. Biol. Med. 45, 231\u2013241 (2008)","journal-title":"Free Radic. Biol. Med."},{"key":"BFnature16969_CR23","doi-asserted-by":"publisher","first-page":"e104104","DOI":"10.1371\/journal.pone.0104104","volume":"9","author":"Y Cao","year":"2014","unstructured":"Cao, Y., Rathmell, J. C. & Macintyre, A. N. Metabolic reprogramming towards aerobic glycolysis correlates with greater proliferative ability and resistance to metabolic inhibition in CD8 versus CD4 T cells. PLoS ONE 9, e104104 (2014)","journal-title":"PLoS ONE"},{"key":"BFnature16969_CR24","doi-asserted-by":"publisher","first-page":"869","DOI":"10.3109\/10715762.2013.837577","volume":"47","author":"Y Sumida","year":"2013","unstructured":"Sumida, Y., Niki, E., Naito, Y. & Yoshikawa, T. Involvement of free radicals and oxidative stress in NAFLD\/NASH. Free Radic. Res. 47, 869\u2013880 (2013)","journal-title":"Free Radic. Res."},{"key":"BFnature16969_CR25","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.celrep.2014.06.043","volume":"8","author":"PE Porporato","year":"2014","unstructured":"Porporato, P. E. et al. A mitochondrial switch promotes tumor metastasis. Cell Reports 8, 754\u2013766 (2014)","journal-title":"Cell Reports"},{"key":"BFnature16969_CR26","doi-asserted-by":"publisher","first-page":"3046","DOI":"10.1194\/jlr.M007096","volume":"51","author":"AE Feldstein","year":"2010","unstructured":"Feldstein, A. E. et al. Mass spectrometric profiling of oxidized lipid products in human nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. J. Lipid Res. 51, 3046\u20133054 (2010)","journal-title":"J. Lipid Res."},{"key":"BFnature16969_CR27","doi-asserted-by":"publisher","first-page":"4722","DOI":"10.1158\/0008-5472.CAN-12-3797","volume":"73","author":"K Muir","year":"2013","unstructured":"Muir, K. et al. Proteomic and lipidomic signatures of lipid metabolism in NASH-associated hepatocellular carcinoma. Cancer Res. 73, 4722\u20134731 (2013)","journal-title":"Cancer Res."},{"key":"BFnature16969_CR28","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1136\/gut.2007.134288","volume":"57","author":"N Beraza","year":"2008","unstructured":"Beraza, N. et al. Pharmacological IKK2 inhibition blocks liver steatosis and initiation of non-alcoholic steatohepatitis. Gut 57, 655\u2013663 (2008)","journal-title":"Gut"},{"key":"BFnature16969_CR29","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nature10809","volume":"482","author":"J Henao-Mejia","year":"2012","unstructured":"Henao-Mejia, J. et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 482, 179\u2013185 (2012)","journal-title":"Nature"},{"key":"BFnature16969_CR30","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1002\/hep.26081","volume":"57","author":"K Miura","year":"2013","unstructured":"Miura, K. et al. Toll-like receptor 2 and palmitic acid cooperatively contribute to the development of nonalcoholic steatohepatitis through inflammasome activation in mice. Hepatology 57, 577\u2013589 (2013)","journal-title":"Hepatology"},{"key":"BFnature16969_CR31","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1084\/jem.20080308","volume":"205","author":"J Andersson","year":"2008","unstructured":"Andersson, J. et al. CD4+ FoxP3+ regulatory T cells confer infectious tolerance in a TGF-\u03b2-dependent manner. J. Exp. Med. 205, 1975\u20131981 (2008)","journal-title":"J. Exp. Med."},{"key":"BFnature16969_CR32","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.ccr.2014.07.001","volume":"26","author":"H Nakagawa","year":"2014","unstructured":"Nakagawa, H. et al. ER stress cooperates with hypernutrition to trigger TNF-dependent spontaneous HCC development. Cancer Cell 26, 331\u2013343 (2014)","journal-title":"Cancer Cell"},{"key":"BFnature16969_CR33","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1172\/JCI8922","volume":"105","author":"Y Ikehara","year":"2000","unstructured":"Ikehara, Y. et al. CD4+ V\u03b114 natural killer T cells are essential for acceptance of rat islet xenografts in mice. J. Clin. Invest. 105, 1761\u20131767 (2000)","journal-title":"J. Clin. Invest."},{"key":"BFnature16969_CR34","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1172\/JCI35722","volume":"119","author":"R Hanczko","year":"2009","unstructured":"Hanczko, R. et al. Prevention of hepatocarcinogenesis and increased susceptibility to acetaminophen-induced liver failure in transaldolase-deficient mice by N-acetylcysteine. J. Clin. Invest. 119, 1546\u20131557 (2009)","journal-title":"J. Clin. Invest."},{"key":"BFnature16969_CR35","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1053\/gast.2002.32388","volume":"122","author":"S Radaeva","year":"2002","unstructured":"Radaeva, S. et al. Interferon-\u03b1 activates multiple STAT signals and down-regulates c-Met in primary human hepatocytes. Gastroenterology 122, 1020\u20131034 (2002)","journal-title":"Gastroenterology"},{"key":"BFnature16969_CR36","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0021-9258(19)81445-X","volume":"242","author":"RF Chen","year":"1967","unstructured":"Chen, R. F. Removal of fatty acids from serum albumin by charcoal treatment. J. Biol. Chem. 242, 173\u2013181 (1967)","journal-title":"J. Biol. Chem."},{"key":"BFnature16969_CR37","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/B978-0-12-416618-9.00020-0","volume":"542","author":"FK Huynh","year":"2014","unstructured":"Huynh, F. K., Green, M. F., Koves, T. R. & Hirschey, M. D. Measurement of fatty acid oxidation rates in animal tissues and cell lines. Methods Enzymol. 542, 391\u2013405 (2014)","journal-title":"Methods Enzymol."},{"key":"BFnature16969_CR38","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/B978-0-12-416618-9.00007-8","volume":"542","author":"M Pelletier","year":"2014","unstructured":"Pelletier, M., Billingham, L. K., Ramaswamy, M. & Siegel, R. M. Extracellular flux analysis to monitor glycolytic rates and mitochondrial oxygen consumption. Methods Enzymol. 542, 125\u2013149 (2014)","journal-title":"Methods Enzymol."},{"key":"BFnature16969_CR39","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner, D. E. et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41, 1313\u20131321 (2005)","journal-title":"Hepatology"},{"key":"BFnature16969_CR40","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/hep.510240201","volume":"24","author":"P Bedossa","year":"1996","unstructured":"Bedossa, P. & Poynard, T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 24, 289\u2013293 (1996)","journal-title":"Hepatology"},{"key":"BFnature16969_CR41","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1053\/j.gastro.2008.03.020","volume":"135","author":"B Hoechst","year":"2008","unstructured":"Hoechst, B. et al. A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4+CD25+Foxp3+ T cells. Gastroenterology 135, 234\u2013243 (2008)","journal-title":"Gastroenterology"}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nature16969.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature16969","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature16969.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:49:55Z","timestamp":1684417795000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nature16969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":41,"journal-issue":{"issue":"7593","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["BFnature16969"],"URL":"https:\/\/doi.org\/10.1038\/nature16969","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"17 November 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}